🇺🇸 FDA
Patent

US 10087444

MicroRNA composition for the treatment of neuroblastoma

granted A61KA61K31/713A61K45/06

Quick answer

US patent 10087444 (MicroRNA composition for the treatment of neuroblastoma) held by The Board of Regents of the University of Texas System expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/713, A61K45/06